Article Details
Retrieved on: 2021-03-09 20:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The novel CD19-targeted monoclonal antibody tafasitamab [Monjuvi] in combination with lenalidomide [Revlimid] is another particularly interesting ...
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here